MACS® Immuno-Oncology Days

MACS Dendritic Cells Day in Barcelona

Friday, July 5, 2019
9:00 a.m.–2:00 p.m.
Auditori CEK, C/Rosselló 149–153, Barcelona

Attendance is free of charge.
To register, please e-mail event_es@miltenyibiotec.es or call +34 91 512 12 90

Agenda

09:00 a.m.	Registration
09:30 a.m.	Introduction Daniel Benitez-Ribas Dept. of Immunology, Hospital Clinic de Barcelona, IDIBAPS, Spain
09:45 a.m.	Redefining bovine and porcine in vitro models of antigen presenting cells Maria Montoya Centro de Investigaciones Biológicas, CIB-CSIC, Madrid, Spain
10:15 a.m.	T_H1 priming by vaccine dendritic cells depends on IL-12 production by endogenous migratory XCR1⁺dendritic cells Manfred Lutz Institute for Virology and Immunobiology, Julius-Maximilian University of Würzburg, Germany
10:45 a.m.	Autologous tolerogenic dendritic cells for rheumatoid arthritis: the AuToDeCRA study Catharien Hilkens Institute of Cellular Medicine, Newcastle University, UK
11:15 a.m.	Tumor-derived dendritic cells to slow down tumor growth Damya Laoui Vrije Universiteit Brussel, VIB, Belgium
11:45 a.m.	Coffee break
12:15 p.m.	Human pDCs orchestrate the attraction of cytolytic immune effector cells in melanoma DC-vaccination Georgina Flórez Dept. of Tumor Immunology, Radboud Institute for Molecular Life Sciences, Nijmegen, Netherlands
12:45 p.m.	Update on monocyte-derived dendritic cell vaccinations to treat leukemia and solid tumors Evelien Smits Center for Cell Therapy and Regenerative Medicine, Antwerp University Hospital, Belgium
01:15 p.m.	Personalized whole tumor antigen vaccines in ovarian cancer: using tumors for therapy Lana Kandalaft Center of Experimental Therapeutics, Ludwig Institute for Cancer Research, Lausanne, Switzerland
01:45 p.m.	Discussion
02:00 p.m.	Refreshments and networking

Discover